Cargando…
Aspirin metabolites 2,3-DHBA and 2,5-DHBA inhibit cancer cell growth: Implications in colorectal cancer prevention
Although compelling evidence exists on the ability of aspirin to treat colorectal cancer (CRC), and numerous theories and targets have been proposed, a consensus has not been reached regarding its mechanism of action. In this regard, a relatively unexplored area is the role played by aspirin metabol...
Autores principales: | Sankaranarayanan, Ranjini, Valiveti, Chaitanya K., Dachineni, Rakesh, Kumar, D. Ramesh, Lick, Tana, Bhat, G. Jayarama |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896348/ https://www.ncbi.nlm.nih.gov/pubmed/31746356 http://dx.doi.org/10.3892/mmr.2019.10822 |
Ejemplares similares
-
Regulation of mammalian siderophore 2,5-DHBA in the innate immune response to infection
por: Liu, Zhuoming, et al.
Publicado: (2014) -
Salicylic acid metabolites and derivatives inhibit CDK activity: Novel insights into aspirin's chemopreventive effects against colorectal cancer
por: Dachineni, Rakesh, et al.
Publicado: (2017) -
Comparative Analysis of Catabolic and Anabolic Dehydroshikimate Dehydratases for 3,4-DHBA Production in Escherichia coli
por: Shmonova, Ekaterina A., et al.
Publicado: (2022) -
Do Aspirin and Flavonoids Prevent Cancer through a Common Mechanism Involving Hydroxybenzoic Acids?—The Metabolite Hypothesis
por: Sankaranarayanan, Ranjini, et al.
Publicado: (2020) -
The Flavonoid Metabolite 2,4,6-Trihydroxybenzoic Acid Is a CDK Inhibitor and an Anti-Proliferative Agent: A Potential Role in Cancer Prevention
por: Sankaranarayanan, Ranjini, et al.
Publicado: (2019)